ClassID:

21647

A61K2300/00 - page 15 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#4201
20130011470
2013-01-10

Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof

#4202
20130011469
2013-01-10

KRILL OIL AND CAROTENOID COMPOSITION, ASSOCIATED METHOD AND DELIVERY SYSTEM

#4203
20130011467
2013-01-10

Method of treating malignant solid tumors using transcatheter arterial chemoembolization (TACE)

#4204
20130011464
2013-01-10

DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS

#4205
20130011453
2013-01-10

Buffered microencapsulated compositions and methods

#4206
20130011452
2013-01-10

Topical foam composition

#4207
20130011443
2013-01-10

Human respiratory syncytial virus vaccine

#4208
20130011442
2013-01-10

Method for repair of articular cartilage defect and a device used therein

#4209
20130011417
2013-01-10

Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives

#4210
20130011410
2013-01-10

Egg White Antibodies for Prevention and Treatment of Specific Localized Intestinal Infections and Diseases Associated with a Pathogenic Organism or Molecule

#4211
20130011405
2013-01-10

Antagonist anti-CD40 monoclonal antibodies and methods for their use

#4212
20130011396
2013-01-10

TREATMENT PROTOCOL

#4213
20130011382
2013-01-10

Fibrinogen Preparations Enriched In Fibrinogen With An Extended Alpha Chain

#4214
20130011376
2013-01-10

Methods for Enhancing Natural Killer Cell Proliferation and Activity

#4215
20130011373
2013-01-10

SIDE POPULATION CELLS IN CARDIAC REPAIR

#4216
20130011368
2013-01-10

Metabolically Active Micro-Organisms and Methods for Their Production

#4217
20130011366
2013-01-10

Therapeutic Agent for infections, and treatment method using the same

#4218
20130011364
2013-01-10

MOLECULARLY IMPRINTED POLYMERS FOR ELIMINATING METABOLITES

#4219
20130011344
2013-01-10

Use of iminocyclitols as inhibitors of bacterial adherence to epithelial cells

#4220
20130011337
2013-01-10

Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases

#4221
20130006255
2013-01-03

Method and apparatus for determining acetabular component positioning

#4222
20130005959
2013-01-03

ANTI-ALLERGIC AGENT

#4223
20130005830
2013-01-03

SANDALWOOD OIL AND ITS USES

#4224
20130005828
2013-01-03

Composition and method to alleviate joint pain

#4225
20130005823
2013-01-03

METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS

#4226
20130005821
2013-01-03

Intravenous administration of tramadol

#4227
20130005819
2013-01-03

CONTACT LENS DISINFECTING SOLUTIONS

#4228
20130005814
2013-01-03

METHODS AND COMPOSITIONS FOR FACILITATING WEIGHT LOSS BY ADMINISTRATION OF THYROID HORMONES

#4229
20130005799
2013-01-03

Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

#4230
20130005798
2013-01-03

Antiprotozoal compound derived from coelenterata

#4231
20130005793
2013-01-03

Compositions and methods for inhibiting gene expression of hepatitis B virus

#4232
20130005783
2013-01-03

Prevention And Treatment Of Diseases Caused By Elevated Levels Of Deoxy-Sphingolipids

#4233
20130005774
2013-01-03

Topical foam composition

#4234
20130005762
2013-01-03

COMBINATION OF DROLOXIFENE AND CLOPIDOGREL

#4235
20130005757
2013-01-03

Methods of treating mixed dyslipidemia

#4236
20130005753
2013-01-03

Heterobicyclic carboxamides as inhibitors for kinases

#4237
20130005751
2013-01-03

Heterobicyclic carboxamides as inhibitors for kinases

#4238
20130005750
2013-01-03

Heterobicyclic carboxamides as inhibitors for kinases

#4239
20130005746
2013-01-03

Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors

#4240
20130005745
2013-01-03

Inhibitors of Bruton's tyrosine kinase

#4241
20130005742
2013-01-03

Substituted Diphenylpyrazine Derivatives

#4242
20130005734
2013-01-03

THERAPEUTIC COMPOSITIONS

#4243
20130005733
2013-01-03

COMBINATION ANTI-CANCER THERAPY

#4244
20130005711
2013-01-03

Fasudil in combination therapies for the treatment of pulmonary arterial hypertension

#4245
20130005699
2013-01-03

METHODS AND PRODUCTS FOR TREATMENT OF DISEASES

#4246
20130005692
2013-01-03

SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME

#4247
20130005690
2013-01-03

S-nitrosylation of glucosylating toxins and uses therefor

#4248
20130005685
2013-01-03

Starch derivative mixtures

#4249
20130005683
2013-01-03

GLYCINE BETAINE AND ITS USE

#4250
20130005682
2013-01-03

HYDROXYTYROSOL COMPOSITIONS FOR TREATMENT OF CARTILAGE INJURIES IN JOINTS

#4251
20130005681
2013-01-03

Compositions and methods for stabilized polysaccharide formulations

#4252
20130005680
2013-01-03

Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture

#4253
20130005679
2013-01-03

Multivitamin Compositions and Methods for Improving Health

#4254
20130005676
2013-01-03

ENHANCING THE THERAPEUTIC EFFECT OF ACUPUNCTURE WITH ADENOSINE

#4255
20130005670
2013-01-03

COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY

#4256
20130005664
2013-01-03

THERAPEUTIC AGENTS COMPRISING ELASTIC PEPTIDES

#4257
20130005661
2013-01-03

Pharmaceutical compositions

#4258
20130005655
2013-01-03

Methods of treating insomnia using a combination therapy of low-dose doxepin and zolpidem

#4259
20130005650
2013-01-03

Methods and compositions for treating diseases associated with pathogenic proteins

#4260
20130005649
2013-01-03

Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin

#4261
20130004605
2013-01-03

Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells

#4262
20130004602
2013-01-03

LOTION COMPOSITION AND FIBROUS STRUCTURE COMPRISING SAME

#4263
20130004599
2013-01-03

FORMULATION FOR TRANSDERMAL DELIVERY TO PROMOTE SLEEP

#4264
20130004598
2013-01-03

Herbal preparation for anemia and a manufacture method thereof

#4265
20130004597
2013-01-03

Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells

#4266
20130004595
2013-01-03

Compositions and methods for treating skin conditions

#4267
20130004594
2013-01-03

Oral rehydration composition

#4268
20130004591
2013-01-03

Homeopathic formulation consisting of and spp

#4269
20130004590
2013-01-03

ZINC OXIDE/ACID CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION

#4270
20130004588
2013-01-03

DIVALENT CATION CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION

#4271
20130004582
2013-01-03

Composition and method to alleviate joint pain

#4272
20130004580
2013-01-03

DIVALENT CATION/TALC CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION

#4273
20130004578
2013-01-03

Solid Pharmaceutical Dosage Formulation

#4274
20130004574
2013-01-03

Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract

#4275
20130004573
2013-01-03

Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

#4276
20130004570
2013-01-03

Nutritional supplement for use under physiologically stressful conditions

#4277
20130004565
2013-01-03

Proteolytic enzyme formulations

#4278
20130004548
2013-01-03

MEDICAL DEVICES HAVING PHARMACOLOGICAL ACTIVE AGENT RELEASING MATERIAL

#4279
20130004533
2013-01-03

Platelet-derived growth factor-BB production promotor, and mesenchymal stem cell production accelerator, stem cell stabilizer and dermal regenerator comprising the same

#4280
20130004515
2013-01-03

Methods for treating reperfusion injuries using flagellin

#4281
20130004511
2013-01-03

COMPOSITION COMPRISING INHIBITORS OF IRS-1 AND OF VEGF

#4282
20130004507
2013-01-03

METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES

#4283
20130004502
2013-01-03

Influenza targets

#4284
20130004498
2013-01-03

DOSING FOR TREATMENT WITH ANTI-EGFL7 ANTIBODIES

#4285
20130004495
2013-01-03

ANTI-NGF ANTIBODIES FOR THE TREATMENT OF VARIOUS DISORDERS

#4286
20130004488
2013-01-03

Anti-cancer agent delivery vehicles capable of improved loading

#4287
20130004482
2013-01-03

Methods of treating breast cancer with anthracycline therapy

#4288
20130004481
2013-01-03

ANTICANCER THERAPY

#4289
20130004477
2013-01-03

Methods for Treating Inflammation and Oxidative Stress Related Diseases

#4290
20130004474
2013-01-03

Soluble physiological chitosan formulations combined with platelet-rich plasma (PRP) for tissue repair

#4291
20130004459
2013-01-03

Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma

#4292
20130004444
2013-01-03

Composition containing at least one C7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails

#4293
20130004436
2013-01-03

Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis

#4294
20120331575
2012-12-27

TRANSGENIC NON-HUMAN ANIMALS

#4295
20120330210
2012-12-27

Antimicrobial silicone-based wound dressings

#4296
20120330019
2012-12-27

Hepatitis C virus inhibitors

#4297
20120329874
2012-12-27

Synergetic composition comprising flavouring substances and organic acids and use thereof

#4298
20120329868
2012-12-27

Paraconic acids as pigmentation activators

#4299
20120329864
2012-12-27

Synergistic effect of tocotrienols and curcumin

#4300
20120329861
2012-12-27

Treatment of cancer using benzoic acid derivatives

#4301
20120329860
2012-12-27

Uses of Beta-Nicotinamide Adenine Dinucleotide

#4302
20120329852
2012-12-27

Composition for preventing the occurrence of cardiovascular event in multiple risk patient

#4303
20120329851
2012-12-27

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders

#4304
20120329846
2012-12-27

THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALPHA PRODUCTION INHIBITOR

#4305
20120329844
2012-12-27

VALSARTAN SALTS

#4306
20120329827
2012-12-27

Derivatives of pyridoxine for inhibiting HIV integrase

#4307
20120329816
2012-12-27

Methods for altering MRNA splicing and treating familial dysautonomia by administering kinetin, benzyladenine, and tocotrienols

#4308
20120329813
2012-12-27

Pemirolast for the Treatment of Systemic Low Grade Inflammation

#4309
20120329805
2012-12-27

Preparations and methods for ameliorating or reducing presbyopia

#4310
20120329802
2012-12-27

Metalloenzyme inhibitor compounds

#4311
20120329798
2012-12-27

METHODS AND COMPOSITIONS FOR TREATING LUEKEMIA

#4312
20120329781
2012-12-27

COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS

#4313
20120329765
2012-12-27

MEDICINAL TARGETED LOCAL LIPOLYSIS

#4314
20120329764
2012-12-27

METHODS AND COMPOSITIONS FOR THE TREATMENT OF MIGRAINE HEADACHES

#4315
20120329750
2012-12-27

Method for producing purified hematinic iron-saccharidic complex and product produced

#4316
20120329748
2012-12-27

Activation and activators of SIRT5

#4317
20120329747
2012-12-27

Hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells

#4318
20120329744
2012-12-27

Doxorubicin adjuvants to reduce toxicity and methods for using the same

#4319
20120329736
2012-12-27

Treatment for gastrointestinal disorders using a selective, site-activated binding system

#4320
20120329734
2012-12-27

Mixture and infusion or drink solution

#4321
20120329733
2012-12-27

METHODS AND PRODUCTS RELATED TO METABOLIC INTERACTIONS IN DISEASE

#4322
20120329714
2012-12-27

Prolactin Induced Increase in Neural Stem Cell Numbers

#4323
20120329712
2012-12-27

Induction of differential stress resistance and uses thereof

#4324
20120329154
2012-12-27

Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages

#4325
20120329153
2012-12-27

CAR RECEPTOR AS A MEDIATOR OF MIGRATORY CELL CHEMOTAXIS AND/OR CHEMOKINESIS

#4326
20120328720
2012-12-27

juice formulations comprising iridoids

#4327
20120328719
2012-12-27

EXTERNAL PREPARATION FOR SKIN

#4328
20120328717
2012-12-27

PHARMACEUTICAL KIT FOR TREATING NEURONAL DAMAGES

#4329
20120328711
2012-12-27

Antimicrobial system for selective, site-activated binding at target sites

#4330
20120328710
2012-12-27

Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide

#4331
20120328709
2012-12-27

Methods of dissolving blood clots and the like

#4332
20120328700
2012-12-27

METHODS AND COMPOSITIONS FOR REGENERATING CONNECTIVE TISSUE

#4333
20120328695
2012-12-27

Compositions and methods for treatment of chronic fatigue

#4334
20120328690
2012-12-27

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#4335
20120328687
2012-12-27

Formulations of selective alpha-2 agonists and methods of use thereof

#4336
20120328672
2012-12-27

COMPOSITION AND METHOD OF SEPARATING BENTONITE INTO PARTICLES HAVING DISCRETE SIZE AND DENSITY RANGES CAPABLE OF BINDING BIOLOGICAL TOXINS AND CHEMOTHERAPEUTIC AGENTS.

#4337
20120328671
2012-12-27

Antibiotic compositions comprising an antibiotic agent and cysteamine

#4338
20120328663
2012-12-27

Composition of beta-glucan and ashwagandha

#4339
20120328633
2012-12-27

Method of reducing recurrence of multiple sclerosis symptoms in a mammal by administering an anti-repulsive guidance molecule neutralizing antibody

#4340
20120328610
2012-12-27

Triazolopyridines

#4341
20120328609
2012-12-27

Modulation of Axon Degeneration

#4342
20120328607
2012-12-27

GENETIC MARKERS INDICATIVE OF A CANCER PATIENT RESPONSE TO TRASTUZUMAB (HERCEPTIN)

#4343
20120328602
2012-12-27

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS

#4344
20120328601
2012-12-27

Modulation of synaptic maintenance

#4345
20120328600
2012-12-27

Injection of fibrin sealant using reconstituted components in spinal applications

#4346
20120328595
2012-12-27

Variant activin receptor polypeptides and uses thereof

#4347
20120328588
2012-12-27

COMPOUND PREPARATION AND ITS USES FOR PREVENTION AND TREATMENT OF HEARING IMPAIRMENT

#4348
20120328573
2012-12-27

Composition for maintaining healthy kidney function

#4349
20120328572
2012-12-27

bacteria for use in treating and preventing infection in aquatic animals

#4350
20120328569
2012-12-27

INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE

#4351
20120328568
2012-12-27

COMPOSITIONS AND USES OF LECTINS

#4352
20120328566
2012-12-27

ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES

#4353
20120328548
2012-12-27

Sanitizing compositions

#4354
20120328545
2012-12-27

Method for treating vascular inflammation, improving skin beauty and improving male sexual function using ginseng berry

#4355
20120325209
2012-12-27

Method for treating early severe diffuse acute respiratory distress syndrome

#4356
20120323211
2012-12-20

Coated balloons for blood vessel stabilization

#4357
20120323178
2012-12-20

BEPOTASTINE COMPOSITIONS

#4358
20120323162
2012-12-20

Methods and Compositions for Treating Conditions of the Eye

#4359
20120322879
2012-12-20

Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders

#4360
20120322877
2012-12-20

(bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders

#4361
20120322871
2012-12-20

Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives

#4362
20120322863
2012-12-20

PREVENTION OF AND COUNTERMEASURES AGAINST MITOCHONDRIAL DISEASE

#4363
20120322850
2012-12-20

TRPM-2 antisense therapy

#4364
20120322840
2012-12-20

Transdermally Absorbable Preparation Containing Basic Anti-Inflammatory Analgesic

#4365
20120322836
2012-12-20

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR STABILIZING THE SAME

#4366
20120322820
2012-12-20

METHODS TO INHIBIT TUMOR CELL GROWTH BY USING PROTON PUMP INHIBITORS

#4367
20120322817
2012-12-20

COMBINATION

#4368
20120322816
2012-12-20

Rutaecarpine derivatives for activating CYP1A2 in a subject

#4369
20120322797
2012-12-20

Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents

#4370
20120322792
2012-12-20

Method and compositions for treating cancer and related methods

#4371
20120322783
2012-12-20

Tumescent antibiotic solution

#4372
20120322777
2012-12-20

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

#4373
20120322773
2012-12-20

MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS

#4374
20120322757
2012-12-20

Methods for Aloe Processing

#4375
20120322746
2012-12-20

METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF OPHTHALMIC DISORDERS

#4376
20120322743
2012-12-20

Compositions and methods for diagnosing and treating melanoma

#4377
20120322736
2012-12-20

Methods for treatment of headaches by administration of oxytocin

#4378
20120322731
2012-12-20

Cytokine containing compositions

#4379
20120322727
2012-12-20

Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders

#4380
20120322725
2012-12-20

Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity

#4381
20120322715
2012-12-20

SERINE HYDROLASE FORMULATION

#4382
20120322672
2012-12-20

METHOD FOR GENERATING AND SELECTING ANTIBODIES AGAINST TARGET PROTEIN

#4383
20120321731
2012-12-20

Pharmaceutical composition for treating diabetes

#4384
20120321729
2012-12-20

NUTRITIONAL FORMULA FOR MANAGING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND LUNG HEALTH

#4385
20120321728
2012-12-20

NUTRITIONAL FORMULA FOR MANAGING ANGINA PECTORIS

#4386
20120321724
2012-12-20

Method of Measuring and Monitoring In Vivo Nitrite Levels

#4387
20120321720
2012-12-20

Therapeutic application of parenteral krill oil

#4388
20120321713
2012-12-20

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#4389
20120321712
2012-12-20

Pharmaceutical composition

#4390
20120321704
2012-12-20

Compound sea cucumber product, preparation method, and dosage forms thereof

#4391
20120321695
2012-12-20

Use of PVP-Iodine Liposomes for Treatment of Herpes

#4392
20120321684
2012-12-20

Color Cosmetic

#4393
20120321671
2012-12-20

Method for reducing heat loss in neonatal mammalian subjects by transplanting brown adipocytes or precursors thereof

#4394
20120321664
2012-12-20

Modulation of yeast-based immunotherapy products and responses

#4395
20120321651
2012-12-20

Anti-IGE Vaccines

#4396
20120321648
2012-12-20

USE OF ISLET GLUCOSE-6-PHOSPHATASE RELATED PROTEIN AS A DIAGNOSTIC TOOL AND THERAPEUTIC TARGET FOR AUTOIMMUNE DIABETES

#4397
20120321640
2012-12-20

VON WILLEBRAND FACTOR SPECIFIC BINDING AGENTS AND USES THEREOF

#4398
20120321637
2012-12-20

COMBINATION CANCER THERAPY WITH HERV INHIBITION

#4399
20120321625
2012-12-20

Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses

#4400
20120321612
2012-12-20

SYSTEMS AND METHODS FOR TREATING POST-OPERATIVE, ACUTE, AND CHRONIC PAIN USING AN INTRA-MUSCULAR CATHETER ADMINISTRATED COMBINATION OF A LOCAL ANESTHETIC AND A NEUROTOXIN PROTEIN

#4401
20120321611
2012-12-20

Replenishment and enrichment of ocular surface lubrication

#4402
20120321605
2012-12-20

Artificial saliva comprising hyaluronic acid

#4403
20120321602
2012-12-20

Omega-3 fatty acid nutriceutical composition and optimization method

#4404
20120321600
2012-12-20

Infant formula with probiotics and milk fat globule membrane components

#4405
20120321597
2012-12-20

METHODS AND COMPOSITIONS FOR REGENERATING CONNECTIVE TISSUE

#4406
20120321571
2012-12-20

PARABEN COMPOSITIONS

#4407
20120321565
2012-12-20

PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST

#4408
20120321564
2012-12-20

Compositions useful for reducing nephrotoxicity and methods of use thereof

#4409
20120321561
2012-12-20

Cancer diagnosis and imaging

#4410
20120318262
2012-12-20

Pyrvinium Wound Treatment Methods and Devices

#4411
20120317678
2012-12-13

Gene Dro1 Controlling Deep-Rooted Characteristics of Plant and Utilization of Same

#4412
20120316249
2012-12-13

LYCOPENE FOR THE TREATMENT FOR METABOLIC DYSFUNCTION

#4413
20120316248
2012-12-13

Compositions and methods for treating parasitic infections

#4414
20120316243
2012-12-13

Enhanced bimatoprost ophthalmic solution

#4415
20120316241
2012-12-13

REMEDY FOR CARTILAGE-RELATED DISEASES

#4416
20120316232
2012-12-13

Combination of a centrally-acting analgesic and a selective cyclooxygenase-2 inhibitor anti-inflammatory agent for the treatment of inflammation and pain in the veterinary field

#4417
20120316217
2012-12-13

COMBINATION FOR THE TREATMENT OF OSTEOARTHRITIS

#4418
20120316213
2012-12-13

Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea

#4419
20120316210
2012-12-13

TOPICAL ANTIPARASITIC FORMULATIONS

#4420
20120316199
2012-12-13

COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, OR AMELIORATING INFLAMMATORY PAIN

#4421
20120316197
2012-12-13

Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases

#4422
20120316189
2012-12-13

METHODS AND COMPOSITIONS FOR REDUCING THE RISK ASSOCIATED WITH THE ADMINISTRATION OF OPIOID ANALGESICS IN PATIENTS DIAGNOSED OR UNDIAGNOSED RESPIRATORY ILLNESS

#4423
20120316164
2012-12-13

METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELLS

#4424
20120316143
2012-12-13

Ophthalmic composition

#4425
20120316133
2012-12-13

Aqueous iron carbohydrate complexes, their production and medicaments containing them

#4426
20120316131
2012-12-13

Stable hyaluronan/steroid formulation

#4427
20120316123
2012-12-13

Dietary supplement composition of citrus derivatives

#4428
20120316122
2012-12-13

PHARMACEUTICAL COMPOSITIONS FOR COMBATING THROMBOTIC DISEASES AND THEIR PREPARATION AND USES

#4429
20120316121
2012-12-13

Materials and Methods for Modulating Arginine Metabolism

#4430
20120316116
2012-12-13

Treatment of coagulation disease by administration of recombinant VWF

#4431
20120316111
2012-12-13

BMP-2 Upregulating Compounds For Healing Bone Tissue And Screening Methods For Selecting Such Compounds

#4432
20120316106
2012-12-13

SYNERGISTIC ANTIBIOTIC COMBINATIONS AND DERIVATIVES

#4433
20120315345
2012-12-13

FUNCTIONAL FOOD AND PHARMACEUTICAL COMPOSITIONS FOR ANTI-OBESITY COMPRISING CAPSANTHIN AND FATTY-ACYL ESTER OF CAPSANTHIN HAVING ANTI-ADIPOGENIC ACTIVITY

#4434
20120315342
2012-12-13

EPITHELIAL CELL-CELL ADHESION ENHANCER, AND AMELIORATING, THERAPEUTIC OR PROPHYLACTIC AGENT FOR ALLERGIC DISEASES USING SAME

#4435
20120315341
2012-12-13

Method for treating an inflammation or lesion caused by a virus

#4436
20120315336
2012-12-13

INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS

#4437
20120315332
2012-12-13

PHARMACEUTICAL COMPOSITION INCLUDING SUNFLOWER EXTRACT, PREPARATIVE METHOD AND USE THEREOF

#4438
20120315328
2012-12-13

Capsule of compound danshen dripping pills

#4439
20120315324
2012-12-13

EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

#4440
20120315320
2012-12-13

Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells

#4441
20120315305
2012-12-13

Dry powder fibrin sealant

#4442
20120315303
2012-12-13

METHODS AND INTRAVASCULAR TREATMENT DEVICES USING PACLITAXEL FOR TREATMENT OF ATHEROSCLEROSIS

#4443
20120315277
2012-12-13

Compositions and Methods for the Therapy and Diagnosis of Influenza

#4444
20120315273
2012-12-13

TREATING SKIN CANCER

#4445
20120315268
2012-12-13

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE

#4446
20120315264
2012-12-13

ZWITTERIONIC IMMUNOMODULATORS FOR THE TEATMENT OF ASTHMA AND ALLERGY

#4447
20120315261
2012-12-13

ANTIBACTERIAL AUXILIARY AGENT COMPRISING KOMBU EXTRACT AS ACTIVE INGREDIENT, ANTIBACTERIAL COMPOSITION, AND FOOD OR BEVERAGE

#4448
20120315258
2012-12-13

strains and methods for reducing disease and enhancing performance

#4449
20120315254
2012-12-13

METHODS AND COMPOSITIONS FOR ENHANCING FAT GRAFT SURVIVAL

#4450
20120315250
2012-12-13

PROBIOTIC BIFIDOBACTERIAL COMPOSITION IN ACCORDANCE WITH SECRETOR BLOOD GROUP STATUS

#4451
20120315249
2012-12-13

Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes

#4452
20120315248
2012-12-13

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATTENUATED ONCOLYTIC VIRUSES

#4453
20120315246
2012-12-13

Compositions and methods for modulating inflammatory and/or immune responses

#4454
20120315243
2012-12-13

Methods for reducing the risk of an unsuccessful pregnancy in a subject having an immune system abberation

#4455
20120315233
2012-12-13

Anthranillic acid amides and derivatives thereof as cosmetic and pharmaceutical active compounds

#4456
20120310183
2012-12-06

Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor

#4457
20120309835
2012-12-06

METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES

#4458
20120309825
2012-12-06

Nitrate esters and their use for the treatment of muscle and muscle related diseases

#4459
20120309800
2012-12-06

Metalloenzyme inhibitor compounds

#4460
20120309779
2012-12-06

Methods and compositions comprising sequential administration opioid receptor agonists

#4461
20120309758
2012-12-06

Modulators of ATP-Binding Cassette transporters

#4462
20120309749
2012-12-06

Piroxicam-containing transdermally absorbable preparation

#4463
20120309744
2012-12-06

DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING HEPATOCELLULAR CARCINOMA

#4464
20120309736
2012-12-06

Cyclic benzimidazole derivatives useful as anti-diabetic agents

#4465
20120309728
2012-12-06

NEW STEROID INHIBITORS OF PGP FOR USE FOR INHIBITING MULTIDRUG RESISTANCE

#4466
20120309727
2012-12-06

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

#4467
20120309726
2012-12-06

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

#4468
20120309725
2012-12-06

COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST

#4469
20120309722
2012-12-06

THERAPEUTIC REGIMENS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS

#4470
20120309715
2012-12-06

Use of Simethicone in Constipated Patients

#4471
20120309710
2012-12-06

Compound sea cucumber preparation and manufacturing method thereof

#4472
20120309709
2012-12-06

Ion-Channel Regulator Compositions and Methods of Using Same

#4473
20120309706
2012-12-06

COMBINED TREATMENT OF PANCREATIC CANCER WITH GEMCITABINE AND MASITINIB

#4474
20120309704
2012-12-06

COMPOSITIONS FOR TREATMENT OF CHEMORESISTANT AND/OR POTENTIALLY CHEMORESISTANT LEUKAEMIAS

#4475
20120309683
2012-12-06

USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES

#4476
20120309681
2012-12-06

Treating or ameliorating some neuroendocrine disorders in male with help of prolactin

#4477
20120309677
2012-12-06

METHODS FOR REGULATING BLOOD GLUCOSE LEVELS

#4478
20120309672
2012-12-06

Treatment of extracellular matrix to reduce inflammation

#4479
20120309087
2012-12-06

CANCER THERAPY

#4480
20120309035
2012-12-06

STABLE SOLUTION

#4481
20120308675
2012-12-06

COMPOSITIONS FOR REDUCING FAT ON THE HUMAN BODY

#4482
20120308670
2012-12-06

Topical Medicament for the Treatment of Psoriasis

#4483
20120308669
2012-12-06

CHOCOLATE CANDIES FORTIFIED WITH NATURAL AMINO ACIDS AND/OR HERBAL NUTRIENTS FOR RELIEF OF INSOMNIA, PMS, AND DIFFICULTY CONCENTRATING

#4484
20120308668
2012-12-06

MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY

#4485
20120308665
2012-12-06

Material for osteoplasty and tissue engineering

#4486
20120308654
2012-12-06

ABUSE-PROOFED DOSAGE FORM

#4487
20120308637
2012-12-06

Compositions comprising extracts of , tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith

#4488
20120308634
2012-12-06

GUM DELIVERY SYSTEM

#4489
20120308623
2012-12-06

COMPOSITION COMPRISING NANOPARTICLES OF TI02

#4490
20120308612
2012-12-06

Compositions and methods for preparation of poorly water soluble drugs with increased stability

#4491
20120308562
2012-12-06

METHODS OF TREATING MESOTHELIOMA WITH A PI3K INHIBITOR COMPOUND

#4492
20120308560
2012-12-06

Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272

#4493
20120308559
2012-12-06

METHOD OF TREATING HEMOLYTIC DISEASE

#4494
20120308558
2012-12-06

Methods of using antibodies that bind the glutamate ligand binding region of Notch1

#4495
20120308553
2012-12-06

ORAL MEDICATION FOR THE TREATMENT OF HEMORRHOIDS AND METHOD OF USE

#4496
20120308552
2012-12-06

Hemostatic bio-material composition and method

#4497
20120308550
2012-12-06

Method of Using Fish Plasma Components to Promote Functional Recovery in the Mammialian CNS

#4498
20120308541
2012-12-06

PHARMACEUTICAL COMPOSITION FOR TREATING THE GASTROINTESTINAL TRACT

#4499
20120308527
2012-12-06

PREVENTION OF OPPORTUNISTIC INFECTIONS IN IMMUNE-COMPRISED SUBJECTS

#4500
20120308524
2012-12-06

COMPOSITION FOR USE IN THE THERAPY OF LACTOSE INTOLERANCE OR CONDITIONS ARISING FROM LACTASE DEFICIENCY